Back to search

Article

A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort study

2024-10-23

Abstract excerpt

<title>Abstract</title> <p>Background: Patients with end-stage renal disease (ESRD) have compromised immune systems, possibly reducing their vaccine-induced antibody responses compared to the general population. This study aims to determine the immunogenicity of this group to the COVID-19 vaccine. <h4>Methods:</h4> Haemodialysis patients receiving the Pfizer-BioNTech mRNA vaccine were followed for at least 13 mon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e128cd2-127c-578d-9991-8d6504c5a1a9
DOI
10.21203/rs.3.rs-5308635/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studyDOI 10.21203/rs.3.rs-5308635/v1
A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individualsSemantic proximity
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisSemantic proximity
Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsSemantic proximity
Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case ReportSemantic proximity
Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patientsSemantic proximity
Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative StudySemantic proximity
Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity
Antibody and T-Cell Responses 6 Months after Covid-19 mRNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney TransplantSemantic proximity
Improved SARS-CoV-2 neutralization of Delta and Omicron variants of concern after fourth vaccination in hemodialysis patientsSemantic proximity
Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysisSemantic proximity
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsSemantic proximity
Select a neighboring publication to make it the new centre.